Cargando...

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

PURPOSE: The increase in clinical trials with androgen receptor (AR)-targeting drugs emphasizes the need of clarifying the role of AR expression in different breast cancer subtypes. AR confers good prognosis in estrogen receptor positive (ER+) breast cancer, but its role in ER-negative (ER−) breast...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Main Authors: Elebro, Karin, Bendahl, Pär-Ola, Jernström, Helena, Borgquist, Signe
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5602002/
https://ncbi.nlm.nih.gov/pubmed/28643022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4343-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!